Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4)

被引:948
作者
Achen, MG
Jeltsch, M
Kukk, E
Mäkinen, T
Vitali, A
Wilks, AF
Alitalo, K
Stacker, SA
机构
[1] Royal Melbourne Hosp, Ludwig Inst Canc Res, Melbourne, Vic 3050, Australia
[2] Univ Helsinki, Haartman Inst, Mol Canc Biol Lab, Helsinki 00014, Finland
关键词
D O I
10.1073/pnas.95.2.548
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
We have identified a member of the VEGF family by computer-based homology searching and have designated it VEGF-D. VEGF-D is most closely related to VEGF-C by virtue of the presence of N- and C-terminal extensions that are not found in other VEGF family members, In adult human tissues, VEGF-D mRNA is most abundant in heart, lung, skeletal muscle, colon, and small intestine, Analyses of VEGF-D receptor specificity revealed that VEGF-D is a ligand for both VEGF receptors (VEGFRs) VEGFR-2 (Flk1) and VEGFR-3 (Flt4) and can activate these receptors, However, VEGF-D does not bind to VEGFR-1. Expression of a truncated derivative of VEGF-D demonstrated that the receptor-binding capacities reside in the portion of the molecule that is most closely related in primary structure to other VEGF family members and that corresponds to the mature form of VEGF-C. In addition, VEGF-D is a mitogen for endothelial cells. The structural and functional similarities between VEGF-D and VEGF-C define a subfamily of the VEGFs.
引用
收藏
页码:548 / 553
页数:6
相关论文
共 37 条
  • [11] FOS AND BONE CELL-DEVELOPMENT - LESSONS FROM A NUCLEAR ONCOGENE
    GRIGORIADIS, AE
    WANG, ZQ
    WAGNER, EF
    [J]. TRENDS IN GENETICS, 1995, 11 (11) : 436 - 441
  • [12] Hyperplasia of lymphatic vessels in VEGF-C transgenic mice
    Jeltsch, M
    Kaipainen, A
    Joukov, V
    Meng, XJ
    Lakso, M
    Rauvala, H
    Swartz, M
    Fukumura, D
    Jain, RK
    Alitalo, K
    [J]. SCIENCE, 1997, 276 (5317) : 1423 - 1425
  • [13] Proteolytic processing regulates receptor specificity and activity of VEGF-C
    Joukov, V
    Sorsa, T
    Kumar, V
    Jeltsch, M
    ClaessonWelsh, L
    Cao, YH
    Saksela, O
    Kalkkinen, N
    Alitalo, K
    [J]. EMBO JOURNAL, 1997, 16 (13) : 3898 - 3911
  • [14] Joukov V, 1996, EMBO J, V15, P290
  • [15] EXPRESSION OF THE FMS-LIKE TYROSINE KINASE-4 GENE BECOMES RESTRICTED TO LYMPHATIC ENDOTHELIUM DURING DEVELOPMENT
    KAIPAINEN, A
    KORHONEN, J
    MUSTONEN, T
    VANHINSBERGH, VWM
    FANG, GH
    DUMONT, D
    BREITMAN, M
    ALITALO, K
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (08) : 3566 - 3570
  • [16] Kukk E, 1996, DEVELOPMENT, V122, P3829
  • [17] Vascular endothelial growth factor-related protein: A ligand and specific activator of the tyrosine kinase receptor Flt4
    Lee, J
    Gray, A
    Yuan, J
    Luoh, SM
    Avraham, H
    Wood, WI
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (05) : 1988 - 1992
  • [18] The IMAGE consortium: An integrated molecular analysis of genomes and their expression
    Lennon, G
    Auffray, C
    Polymeropoulos, M
    Soares, MB
    [J]. GENOMICS, 1996, 33 (01) : 151 - 152
  • [19] ISOLATION OF A HUMAN PLACENTA CDNA CODING FOR A PROTEIN RELATED TO THE VASCULAR-PERMEABILITY FACTOR
    MAGLIONE, D
    GUERRIERO, V
    VIGLIETTO, G
    DELLIBOVI, P
    PERSICO, MG
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (20) : 9267 - 9271
  • [20] MAGLIONE D, 1993, ONCOGENE, V8, P925